E-tailors Amazon, Flipkart Health Plus and others have reportedly been served show-cause notices for selling drugs online without proper licence. As per updates, the Drugs Controller General of India (DGCI) has served notices to these e-tailors over violation of norms.
According to a PTI report, the show-cause notice to Amazon, Flipkart Health Plus and others by DGCI cited a Delhi High Court order that prohibited online sales of medicines without a licence. It adds that DGCI had also forwarded the order to all state and Union Territories (UTs) for necessary compliance.
The report also adds that as per the show-cause notice issued to these e-tailors, the sale or stock or exhibit or offer for sale or distribution of any drug requires a licence from the concerned state, licensing authority and even the conditions are to be met by the required party. However, in the event of no reply from Amazon, Flipkart Health Plus and others, DGCI may presume that the company has nothing to respond and would take necessary action.
“In spite of the same, you are found to be engaged in such activities without a licence," the notice to the online medicine sellers said........You are hereby asked to show cause within 2 days from the date of issue of this notice, why action shall not be taken against you for sale, or stock, or exhibit or offer for sale or distribution of drugs in contravention of the provisions of the Drugs and Cosmetics Act 1940 and rules made thereunder,” PTI quoted the show-cause notice given to Amazon and Flipkart Health Plus as saying.
In response to this show-cause notice, Flipkart also reportedly commented that the company is responding to this issue carefully.
(With inputs from PTI)